On Monday, Regeneron Pharmaceuticals announced that it would acquire most of 23andMe's assets for $256 million. According to ...

Genetic testing company 23andMe isn’t going away, despite declaring bankruptcy. The company and nearly all of its assets, ...

Regeneron is buying 23andMe for $256M in bankruptcy, gaining access to DNA data from 15 million users to aid drug research.

The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical ...

Regeneron said it will acquire 23andMe’s genomics service and its bank of 15 million customers’ personal and genetic data as ...

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a ...

Genetic testing firm 23andMe must pay customers after personal information was exposed in a cybersecurity incident, if they ...

Hey New Jerseyands, claims are now open for 23andMe's settlement over a data breach — and payouts may be as high as $10,000.

The personal genomics company 23andMe filed for bankruptcy in March and agreed to pay $30 million to affected customers.

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.

We've got all the details about who's eligible for the massive 23andMe data breach settlement and how to make a claim -- plus, who might be able to get as much as $10,000.